BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 1036743)

  • 21. Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour.
    Perry-Keene DA; Warne GL; Martin FI
    Med J Aust; 1976 Oct; 2(16):602-4. PubMed ID: 1036755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of hyperprolactinemia with a new ergot derivative, lergotrile mesylate.
    Sherman BM; Swanson JA; Chapler FK
    Fertil Steril; 1978 Mar; 29(3):291-5. PubMed ID: 565303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Bromergocryptine and the galactorrhea-amenorrhea syndrome.
    Stempel LE
    Ann Intern Med; 1976 Sep; 85(3):401-3. PubMed ID: 962235
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Künzig HJ; Geiger W; Schulz KD; Lose KH
    Arch Gynakol; 1975; 218(2):85-94. PubMed ID: 1174026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
    Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
    Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
    Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
    Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 29. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
    Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of functional amenorrhea-galactorrhea with 2-bromoergocryptine.
    Wiebe RH; Hammond CB; Handwerger S
    Fertil Steril; 1977 Apr; 28(4):426-33. PubMed ID: 321260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of bromocriptine to induce ovulation in the galactorrhea-amenorrhea syndrome [].
    Hernández Ayup S; Muñoz M; González R; Galache P; Guitrón A; Pancardo RM; Forsbach G
    Rev Invest Clin; 1982; 34(2):121-3. PubMed ID: 7123023
    [No Abstract]   [Full Text] [Related]  

  • 32. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M; de Villamizar M
    Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of response to ergocryptine in the galactorrhea-amenorrhea syndrome.
    Corenblum B; Taylor PJ
    Fertil Steril; 1978 Oct; 30(4):388-92. PubMed ID: 581377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of the long-term use of parlodel in different forms of lactorrhea].
    Mel'nichenko GA; Pishulin AA; Gitel' EG; Nazarenko VA
    Sov Med; 1984; (1):59-64. PubMed ID: 6701657
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bromocriptine treatment of infertile women with amenorrhoea--galactorrhoea].
    Nillius SJ; Skarin O
    Lakartidningen; 1977 Nov; 74(46):4110-2. PubMed ID: 926944
    [No Abstract]   [Full Text] [Related]  

  • 36. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.
    Tolis G; Laliberté R; Guyda H; Naftolin F
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1197-9. PubMed ID: 559690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pregnancy after treatment with bromoergocryptin in patient with pituitary tumor. Report of a case].
    Pérez Peña E; Cabeza de Flores A; Flores Lozano F
    Ginecol Obstet Mex; 1979 Jul; 46(273):23-7. PubMed ID: 527849
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperprolactinaemia and luteal insufficiency.
    Seppälä M; Ranta T; Hirvonen E
    Lancet; 1976 Jan; 1(7953):229-30. PubMed ID: 55535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of treatment of galactorrhea-amenorrhea syndrome with bromocryptine (Parlodel)].
    Dudkiewicz J; Blecharz A; Kosowicz J
    Endokrynol Pol; 1978; 29(3):181-90. PubMed ID: 566660
    [No Abstract]   [Full Text] [Related]  

  • 40. [5 cases of hyperprolactinemia. Review of the physiology of prolactin and its role in pathology].
    Gérard J
    Rev Med Liege; 1980 Feb; 35(4):98-112. PubMed ID: 6102408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.